Peter Blume-Jensen has sold ACRV and made no open-market buys since Aug 2026
President and CEO at Acrivon Therapeutics, Inc.
SEC CIK 0001950499 · Filings on SEC.gov ↗
$0Bought
$31KSold
NoneLast buy
Every filing
1 filing since Aug 2026, newest first
Filings come from SEC EDGAR. Not investment advice.